Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
about
Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study.Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma.Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewRegorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study.Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.
P2860
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Phase IB study of sorafenib in ...... with refractory solid tumors.
@en
Phase IB study of sorafenib in ...... with refractory solid tumors.
@nl
type
label
Phase IB study of sorafenib in ...... with refractory solid tumors.
@en
Phase IB study of sorafenib in ...... with refractory solid tumors.
@nl
prefLabel
Phase IB study of sorafenib in ...... with refractory solid tumors.
@en
Phase IB study of sorafenib in ...... with refractory solid tumors.
@nl
P2093
P2860
P1476
Phase IB study of sorafenib in ...... with refractory solid tumors.
@en
P2093
B Schultheis
D Strumberg
M Kornacker
P2860
P2888
P304
P356
10.1007/S00280-011-1685-X
P577
2011-07-08T00:00:00Z
P6179
1016863304